BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prasun P, Ginevic I, Oishi K. Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease. Transl Gastroenterol Hepatol 2021;6:4. [PMID: 33437892 DOI: 10.21037/tgh-20-125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Zhao Y, Yu M, Qin J, Ye B, Wang Q. Mitochondrial Dysfunction and Chronic Liver Disease. Curr Issues Mol Biol 2022;44:3156-65. [PMID: 35877442 DOI: 10.3390/cimb44070218] [Reference Citation Analysis]
2 Assante G, Chandrasekaran S, Ng S, Tourna A, Chung CH, Isse KA, Banks JL, Soffientini U, Filippi C, Dhawan A, Liu M, Rozen SG, Hoare M, Campbell P, Ballard JWO, Turner N, Morris MJ, Chokshi S, Youngson NA. Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease. Genome Med 2022;14:67. [PMID: 35739588 DOI: 10.1186/s13073-022-01071-5] [Reference Citation Analysis]
3 Nascè A, Gariani K, Jornayvaz FR, Szanto I. NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants (Basel) 2022;11:1131. [PMID: 35740032 DOI: 10.3390/antiox11061131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Newman LA, Muller K, Rowland A. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04256-8] [Reference Citation Analysis]
5 Miyahara H, Hasegawa K, Yashiro M, Ohara T, Fujisawa M, Yoshimura T, Matsukawa A, Tsukahara H. Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways. Sci Rep 2022;12:4819. [PMID: 35314758 DOI: 10.1038/s41598-022-08791-z] [Reference Citation Analysis]
6 Rodríguez RM, Cortés-espinar AJ, Soliz-rueda JR, Feillet-coudray C, Casas F, Colom-pellicer M, Aragonès G, Avila-román J, Muguerza B, Mulero M, Salvadó MJ. Time-of-Day Circadian Modulation of Grape-Seed Procyanidin Extract (GSPE) in Hepatic Mitochondrial Dynamics in Cafeteria-Diet-Induced Obese Rats. Nutrients 2022;14:774. [DOI: 10.3390/nu14040774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Schnegelberger RD, Lang AL, Arteel GE, Beier JI. Environmental toxicant-induced maladaptive mitochondrial changes: A potential unifying mechanism in fatty liver disease? Acta Pharm Sin B 2021;11:3756-67. [PMID: 35024304 DOI: 10.1016/j.apsb.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Reza MI, Syed AA, Singh P, Husain A, Gayen JR. Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning. Life Sci 2021;284:119905. [PMID: 34453940 DOI: 10.1016/j.lfs.2021.119905] [Reference Citation Analysis]
9 Fan H, Shen Y, Ren Y, Mou Q, Lin T, Zhu L, Ren T. Combined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease. Nutr Metab (Lond) 2021;18:50. [PMID: 33971886 DOI: 10.1186/s12986-021-00554-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]